[1] RAMACHANDRAN S,ZAIDI F,AGGARWAL A,et al.Recent advances in diagnostic and therapeutic guidelines for primary and secondary hemophagocytic lymphohistiocytosis [J].Blood Cells Mol Dis,2017,64:53-57.
[2] AL-SAMKARI H,BERLINER N.Hemophagocytic lymphohistiocytosis[J].Annu Rev Pathol,2018,13:27-49.
[3] MADKAIKAR M,SHABRISH S,DESAI M.Current updates on lassification,diagnosis and treatment of hemophagocytic lymphohistiocytosis (HLH)[J].Indian J Pediatr,2016,83(5):434-443.
[4] ESTEBAN YM,DE JONG JLO,TESHER MS.An overview of hemophagocytic lymphohistiocytosis[J].Pediatr Ann,2017,46(8):e309-e313.
[5] KIM WY,MONTES-MOJARRO IA,FEND F,et al.Epstein-Barr virus-associated T and NK-cell lymphoproliferative diseases[J].Front Pediatr,2019,7:71.
[6] PARIKH SA,KAPOOR P,LETENDRE L,et al.Prognostic factors and outcomes of adults with hemophagocytic lymphohistiocytosis [J].Mayo Clin Proc,2014,89(4):484-492.
[7] MORIMOTO A,NAKAZAWA Y,ISHII E.Hemophagocytic lymphohistiocytosis:Pathogenesis,diagnosis,and management [J].Pediatr Int,2016,58(9):817-825.
[8] BATU ED,ERDEN A,SEYHOGLU E,et al.Assessment of the HScore for reactive haemophagocytic syndrome in patients with rheumatic diseases [J].Scand J Rheumatol,2017,46(1):44-48.
[9] LIM SH,PARK S,JANG JH,et al.Clinical significance of bone marrow hemophagocytosis in adult patients with malignancy and no-malignancy-induced hemophagocytic lymphohistiocytosis[J].Ann Hematol,2016,95(2):325-335.
[10] SAEED H,WOODS RR,LESTER J,et al.Evaluating the optimal serum ferritin level to identify hemophagocytic lymphohistiocytosis in the critical care setting [J].Int J Hematol,2015,102:195-199.
[11] LEHMBERG K,MCCLAIN KL,JANKA GE,et al.Determination of an appropriate cut-off value for ferritin in the diagnosis of hemophagocytic lymphohistiocytosis [J].Pediatr Blood Cancer,2014,61:2101-2103.
[12] ZHAO XX,LIAN HY,ZHANG L,et al.Significance of serum ferritin level in hemophagocytic lymphohistiocytosis diagnosis[J].Int J Lab Hematol,2019,41(4):503-508.
[13] TSUJI T,HIRANO T,YAMASAKI H,et al.A high sIL-2R/ferritin ratio is a useful marker for the diagnosis of lymphoma-associated hemophagocytic syndrome[J].Ann Hematol,2014,93(5):821-826.
[14] LIN M,PARK S,HAYDEN A,et al.Clinical utility of soluble interleukin-2 receptor in hemophagocytic syndromes:a systematic scoping review[J].Ann Hematol,2017,96(8):1241-1251.
[15] SCHRAM AM,BERLINER N.How I treat hemophagocytic lymphohistiocytosis in the adult patient[J].Blood,2015,125:2908-2914.
[16] ZHUO WB,GAO Y,YANG CY,et al.Clinical characteristics of hemophagocytic syndrome:analysis of 46 cases[J].Journal of Southern Medical University,2018,38(6):769.
[17] OTROCK ZK,EBY CS.Clinical characteristics,prognostic factors,and outcomes of adult patients with hemophagocytic lymphohistiocytosis[J].Am J Hematol,2015,90(3):220-224.